Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells

por Kharaziha, P, Rodriguez, P, Li, Q, Rundqvist, H, Björklund, A-C, Augsten, M, Ullén, A, Egevad, L, Wiklund, P, Nilsson, S, Kroemer, G, Grander, D, Panaretakis, T
Publicado 2012